WELL Health Technologies Corp. (TSX:WELL)

WELL Health Technologies Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	134	133.76	131.67	43.42	48.91	61.92
Cash & Short-Term Investments	134	133.76	131.67	43.42	48.91	61.92
Cash Growth	29.90%	1.58%	203.22%	-11.21%	-21.01%	-28.74%
Accounts Receivable	180.65	170.94	184.51	94.99	78.91	66.02
Other Receivables	-	-	-	1.11	0.57	0.52
Total Trade Receivables	180.65	170.94	184.51	96.1	79.48	66.54
Inventory	2.39	2.47	2.69	1.18	1.37	0.79
Other Current Assets	61.59	62.44	27.25	35.7	21.12	13.08
Total Current Assets	378.62	369.61	346.11	176.4	150.88	142.34
Net Property, Plant & Equipment	127.94	119.41	101.76	102.54	82.54	83.06
Other Intangible Assets	782.94	760.21	573.96	555.2	571.27	576.68
Goodwill	819.2	787.62	565.12	508.06	499.29	471.55
Long-Term Investments	18.47	19.04	173.79	60.86	10.01	10.85
Other Long-Term Assets	38.81	41.01	46.53	6.25	5.06	2.85
Total Assets	2,166	2,097	1,807	1,409	1,319	1,287

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	103.48	91.6	86.58	47.88	50.73	38.71
Short-Term Debt	8.99	6.43	5.53	5.26	30.3	45.91
Current Portion of Long-Term Debt	85.48	83.52	3.85	3.85	3.85	4.24
Current Portion of Leases	28.33	22.8	18.65	14.87	9.11	7.22
Unearned Revenue	32.53	49.41	59.45	6.65	6.8	4.24
Other Current Liabilities	199.12	103.73	208.01	37.45	35.72	37.02
Total Current Liabilities	457.93	357.47	382.08	115.96	136.5	137.34
Long-Term Debt	483.43	420.65	335.98	335.91	263	290.6
Long-Term Leases	66.8	67.26	61.08	66.39	52.16	53.97
Other Long-Term Liabilities	110.55	98.69	50.37	44.9	52.12	97.65
Total Long-Term Liabilities	660.78	586.59	447.42	447.2	367.28	442.22
Total Liabilities	1,119	1,057	877.55	563.16	503.78	579.56

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	814.76	808.06	784.87	751.55	705.19	633.51
Additional Paid-in Capital	50.69	52.51	46.62	54.05	51.77	43.99
Accumulated Other Comprehensive Income	53.03	41.27	67.09	25.65	39.06	5.38
Retained Earnings	-50.69	-38.34	-30.98	-63.58	-63.67	-65.04
Total Common Shareholders' Equity	867.79	863.51	867.61	767.67	732.34	617.85
Minority Interest	179.5	289.32	110.17	78.48	82.91	89.91
Shareholders' Equity	1,047	1,153	977.78	846.15	815.25	707.76
Total Liabilities & Equity	2,166	2,097	1,807	1,409	1,319	1,287

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	673.03	600.65	425.09	426.28	358.42	401.94
Net Cash (Debt)	-539.03	-466.89	-293.42	-382.86	-309.51	-340.02
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-2.12	-1.85	-1.15	-1.62	-1.40	-1.78
Book Value	867.79	863.51	867.61	767.67	732.34	617.85
Book Value Per Share	3.42	3.42	3.41	3.25	3.32	3.24
Tangible Book Value	-734.36	-684.32	-271.47	-295.6	-338.21	-430.38
Tangible Book Value Per Share	-2.89	-2.71	-1.07	-1.25	-1.53	-2.25

Data Source: Fiscal.ai Last updated: May 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 28, 2026

Data Sources Report a data error